Related Experiment Videos
Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships
The Journal of Pharmacology and Experimental Therapeutics
|September 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ethics assessment as an adjunct to risk assessment in the evaluation of developmental neurotoxicants.
Environmental health perspectives·2001
Profiles of nonsteroidal anti-inflammatory drug-induced gastric antral ulcers: A comprehensive review of the preclinical data.
The Journal of pharmacology and experimental therapeutics·2026
Δ9-Tetrahydrocannabinol treatment impairs CD8+ T cell differentiation into interferon gamma-competent CD45RO+ cells.
The Journal of pharmacology and experimental therapeutics·2026
Ranolazine inhibits invasiveness of human breast cancer cells in combination with a tyrosine kinase inhibitor: Dose-dependent synergy.
The Journal of pharmacology and experimental therapeutics·2026
A novel drug sequestrant-based therapeutic candidate reverses methamphetamine-induced hyperthermia and hypermetabolism and abates multiorgan toxicity in rats.
The Journal of pharmacology and experimental therapeutics·2026
Shiheleucel, an allogeneic natural killer cell product expanded under chemically defined conditions, in combination with rituximab-based chemotherapy in relapsed/refractory diffuse large B-cell lymphoma: An exploratory clinical study.
The Journal of pharmacology and experimental therapeutics·2026
Calpeptin and protein kinase C inhibition suppress exosome-associated inflammatory signaling and epidermal dysregulation in a 3-dimensional psoriatic skin model.
The Journal of pharmacology and experimental therapeutics·2026
Methods of predicting clinically significant DRUG-DRUG interactions beyond validated interaction checkers.
Expert opinion on drug metabolism & toxicology·2026
Cholinesterase Inhibitors in Alzheimer's Disease: Medicinal Chemistry, Mechanistic Insights, and Emerging Multitarget Strategies.
CNS & neurological disorders drug targets·2026
Discovery of a Caffeic Acid Thioamide with Potent Activity against Pathogenic Fungi and Fluconazole Tolerance-Eliminating Effects in Candida albicans.
Drug design, development and therapy·2026